eslicarbazepine acetate has been researched along with Stroke in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Bentes, C; Gigli, GL; Knake, S; Koepp, MJ; Magalhães, LM; Mah, YH; Moreira, J; Pereira, A; Serratosa, JM; Soares-da-Silva, P; Trinka, E; Zelano, J | 1 |
Chaves, J; Fernandes, H; Loureiro, R; McMurray, R; Sales, F; Villanueva, V | 1 |
Bhoi, SK; Gupta, DK; Kalita, J; Misra, UK | 1 |
1 trial(s) available for eslicarbazepine acetate and Stroke
Article | Year |
---|---|
Antiepileptogenesis after stroke-trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate.
Topics: COVID-19; Humans; Ischemic Stroke; Pandemics; SARS-CoV-2; Seizures; Stroke | 2023 |
2 other study(ies) available for eslicarbazepine acetate and Stroke
Article | Year |
---|---|
Eslicarbazepine acetate in post-stroke epilepsy: Clinical practice evidence from Euro-Esli.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Epilepsy; Female; Humans; Male; Middle Aged; Seizures; Stroke; Treatment Outcome; Young Adult | 2020 |
Hyponatremia following esclicarbazepine therapy.
Topics: Age Factors; Anticonvulsants; Comorbidity; Dibenzazepines; Dose-Response Relationship, Drug; Drug Evaluation; Female; Follow-Up Studies; Humans; Hyponatremia; Incidence; Male; Middle Aged; Seizures; Sodium; Stroke; Voltage-Gated Sodium Channel Blockers | 2015 |